This approach successfully identified PD-modifying target candidate, TPP1, demonstrating refining predictions from universal models and enabling disease-specific prioritization without the need for custom knowledge graph construction or disease or patient-specific data integration. This evidence concerns the gene TPP1 and Parkinson disease.